Global Infectious Disease Diagnostics Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Infectious Disease Diagnostics Market Insights, Forecast to 2034
Infectious disease diagnostics are medical tests and assays used to identify infectious agents, such as bacteria, viruses, and parasites, in patient samples. They play a crucial role in early detection and effective management of infectious diseases.
Market Analysis and InsightsGlobal Infectious Disease Diagnostics Market
Global Infectious Disease Diagnostics market is expected to reach to US$ 3710 million in 2024, with a positive growth of %, compared with US$ 3644 million in 2022. Backed with the increasing demand from downstream industries, Infectious Disease Diagnostics industry is evaluated to reach US$ 4776.2 million in 2029. The CAGR will be 4.3% during 2024 to 2029.
The market for infectious disease diagnostics is driven by the increasing prevalence of infectious diseases and the need for accurate and rapid diagnostic solutions to control disease outbreaks. The market's growth is also influenced by technological advancements, such as molecular diagnostics and point-of-care testing.
Report Covers
This report presents an overview of global Infectious Disease Diagnostics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Infectious Disease Diagnostics market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Bio Mérieux SA
Roche Diagnostics
Abbott Laboratories
Thermo Fischer Scientific
BD
Bio-Rad Laboratories
Abbott
Danaher
Johnson and Johnson
Guangzhou Wondfo Biotech Co.,Ltd.
Getein Biotech, Inc.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
BGI Genomics Co.,Ltd.
Maccura Biotechnology Co.,Ltd.
Daan Gene
Beijing Strong Biotechnologies,Inc
Shanghai Kehua Bio-Engineering Co.,Ltd.
Guangdong Hybribio Biotech Co.,Ltd.
Shanghai Runda Medical Technology Co.,Ltd.
Tellgen Corporation
Segment by Type
Molecular Diagnostic Technique
Traditional Diagnostic Technique
Hepatitis C
Hepatitis B
Tuberculosis (TB)
Acquired Immunodeficiency Syndrome (AIDS)
Human Papillomavirus (HPV)
Methicillin-resistant Staphylococcus Aureus (MRSA)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Infectious Disease Diagnostics introduction, etc. Infectious Disease Diagnostics Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Infectious Disease Diagnostics
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal Infectious Disease Diagnostics Market
Global Infectious Disease Diagnostics market is expected to reach to US$ 3710 million in 2024, with a positive growth of %, compared with US$ 3644 million in 2022. Backed with the increasing demand from downstream industries, Infectious Disease Diagnostics industry is evaluated to reach US$ 4776.2 million in 2029. The CAGR will be 4.3% during 2024 to 2029.
The market for infectious disease diagnostics is driven by the increasing prevalence of infectious diseases and the need for accurate and rapid diagnostic solutions to control disease outbreaks. The market's growth is also influenced by technological advancements, such as molecular diagnostics and point-of-care testing.
Report Covers
This report presents an overview of global Infectious Disease Diagnostics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Infectious Disease Diagnostics market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Bio Mérieux SA
Roche Diagnostics
Abbott Laboratories
Thermo Fischer Scientific
BD
Bio-Rad Laboratories
Abbott
Danaher
Johnson and Johnson
Guangzhou Wondfo Biotech Co.,Ltd.
Getein Biotech, Inc.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
BGI Genomics Co.,Ltd.
Maccura Biotechnology Co.,Ltd.
Daan Gene
Beijing Strong Biotechnologies,Inc
Shanghai Kehua Bio-Engineering Co.,Ltd.
Guangdong Hybribio Biotech Co.,Ltd.
Shanghai Runda Medical Technology Co.,Ltd.
Tellgen Corporation
Segment by Type
Molecular Diagnostic Technique
Traditional Diagnostic Technique
Segment by Application
Hepatitis C
Hepatitis B
Tuberculosis (TB)
Acquired Immunodeficiency Syndrome (AIDS)
Human Papillomavirus (HPV)
Methicillin-resistant Staphylococcus Aureus (MRSA)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Infectious Disease Diagnostics introduction, etc. Infectious Disease Diagnostics Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Infectious Disease Diagnostics
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports